Document |
Document Title |
JP5449260B2 |
|
JP2014040436A |
To provide a pest control agent and/or a herbicide and/or a microbicide.A 4-biphenyl-substituted pyrazolidine-3,5-dione derivative represented by the following general formula (I) and a selective herbicide which contains the same are pro...
|
JP5434821B2 |
|
JP5436448B2 |
|
JP2013227440A |
To provide a polyester film that has excellent hydrolysis resistance and good film thickness uniformity, and can exhibit good adhesion to a functional layer after being subjected to a wet heat treatment when used as a back sheet for a so...
|
JP5334115B2 |
To provide an optically responsive chiral compound. The optically responsive chiral compound is represented by general formula (1). A nematic liquid crystal mixture containing this optically responsive chiral compound is also provided.
|
JP5291854B2 |
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; L represents hydrogen or a negative charg...
|
JP5266499B2 |
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; L represents hydrogen or a negative charg...
|
JP2013527837A |
Disclosed is a method for preparing a poly(ethersulfonimide or ethersulfonamide) copolymer using cyclic oligomers, and more particularly, to a method for preparing a poly(ethersulfonimide or ethersulfonamide) copolymer by preparing a cyc...
|
JP5196788B2 |
The invention relates to cyclic depsipeptides, especially 18-membered cyclohexadepsipeptides of general formula (I) and the salts thereof, wherein R1 represents nitrobenzyl or R'R''N-benzyl-wherein R' and R'' independently represent hydr...
|
JP2013508323A |
The present invention relates to novel amide compounds of formula I, and their use as anti-tumoral and pro-apoptotic agents. The invention includes the use of such compounds in medicine, in relation to cancer disease as well as other dis...
|
JP5139999B2 |
The present invention relates generally to novel macrocycles of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein the variables A, B, L, M, W, Z, R1, R2, R3, R4, R5, R6, R...
|
JP5133027B2 |
To provide a new agricultural/horticultural bactericide and to provide a production method of a new compound as an effective ingredient thereof. The agricultural/horticultural bactericide comprises as an effective ingredient at least one...
|
JP2013014628A |
To provide heterocyclic aspartyl protease inhibitors, pharmaceutical compositions comprising the compounds, their use in the treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, and their use as inhibitors of t...
|
JP5117858B2 |
A process for the preparation of [1,4,5]-oxadiazepine derivatives by reaction of 4,5-diacyl-[1,4,5]-oxadiazepines with a base.
|
JP5078619B2 |
The present invention relates to the use of endoparasiticidal depsipeptides for producing pharmaceuticals for preventing vertical infection with endoparasites.
|
JP5061138B2 |
Preparation of 3-(1-hydroxyphenyl-1-alkoxyiminomethyl)dioxazine derivatives of formula (I), comprises: (a) rearranging O-hydroxyethyl-O'-alkyl-benzofuran-dionedioxime optionally in the presence of a diluent and optionally in the presence...
|
JP2012522746A |
The present invention discloses a process for dimethylation of active methylene groups. Specifically, the invention discloses a process for preparing 3-amino-2,2-dimethylpropanamide. Compounds produced by the present dimethylation proces...
|
JP5025652B2 |
An amide is formed by reacting an α-ketoacid or salt thereof in a decarboxylative condensation reaction with an amine or salt thereof comprising a nitrogen covalently bound to an atom selected from oxygen, nitrogen, and sulfur. The amid...
|
JP2012167067A |
To clarify a molecular structure of a metal salen complex exhibiting a pharmacological effect, and to provide a metal salen complex including such a molecular structure, as well as a derivative of the complex.This metal salen complex com...
|
JP5020441B2 |
Process for the polymerization of unsaturated vinyl and/or vinylidene monomers which comprises reacting one or more monomers in the presence of heterocyclic initiators having a nitrogen atom bound to an oxygen atom at a temperature rangi...
|
JP5014978B2 |
A compound represented by the general formula (I) or a salt thereof: [T represents oxygen atom and the like; V represents CH 2 and the like; R O1 to R O4 represent hydrogen atom and the like; A represents a linear alkylene group or linea...
|
JP5004075B2 |
To provide a new cyclic ether amide lipid constructing molecular aggregates by self-organization, and a lipid membrane forming a moderate intramolecular hydrogen bond. This new cyclic ether amide lipid of 2 glycerol derivatives and 2 lon...
|
JP4968845B2 |
Disclosed are compounds of the formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein W is a bond, —C(═S)—, —S(O)—, —S(O)2—, —C(═O)—, —O—, —C(R6)(R7)—, —N(R5)...
|
JP2012067103A |
To provide a new compound which is useful for treatment of Vancomycin-resistant bacteria infection.Following compounds are illustrated as new peptoid compounds, namely, methyl(2S, 5S, 8R/S)-8-acetamide-2-allyl-9-[6-allyl-9-t-butoxycarbon...
|
JP4897170B2 |
Compositions and methods for selectively binding metal ions from source solutions are disclosed. The compositions include 1) polyamide-containing ligands covalently bonded to a particulate solid support, and 2) polyamide-containing polym...
|
JP4885067B2 |
The present invention relates to compounds of the formulaQ is selected from the group consisting ofG is selected from the group consisting of alkyl, substituted alkyl, substituted or unsubstituted aryl, heterocyclo,W is O or NR15;X is O ...
|
JP4854853B2 |
Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having general structure (A):
|
JP4824668B2 |
Carbamoylalkyl N-((hetero)aryl-substituted alkyl)-carbamates (I) are new. Carbamates of formula (I) and their acid addition salts, hydrates and solvates are new. A : one or more of X, Y and/or Z; X : CH 2 (optionally substituted (os) by ...
|
JP4795242B2 |
Amidines and derivatives thereof of formula (I) are described. The process for their preparation and pharmaceutical compositions thereof are also described. The amidines of the invention are useful in the inhibition of chemotaxis of neut...
|
JP4748912B2 |
The present invention discloses novel macrocyclic compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprisin...
|
JP4743382B2 |
A medicament having inhibitory activity against NF- kappa B activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacolo...
|
JP4734656B2 |
|
JP2011121966A |
To provide cationic lipids and compositions of the cationic lipids having utility in lipid aggregates for delivery of macromolecules and other materials into cells.There are provided compounds expressed by general structural formula. The...
|
JP2011517688T |
The new carboxylic acid derivative in which the present invention has the oxo substitution aza-heterocyclic moiety structure of formula (I), It is related with those use for the medicinal manufacture of especially the for the disposal of...
|
JP4673833B2 |
The present invention is directed to compounds of formula (I) which are inhibitors of the beta-secretase enzyme and that are useful in the treatment or prevention of diseases in which the beta-secretase enzyme in involved, such as Alzhei...
|
JP2011057678A |
To provide a novel agricultural and horticultural fungicide.N-phenylamidine derivatives expressed by general formula (I) are provided. (In the formula, R1 represents alkyl, alkenyl, alkynyl, carbocyclyl, heterocyclyl or H; R2 and R3 repr...
|
JP4637174B2 |
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cathepsin S.
|
JP4628366B2 |
The present invention relates to novel macrocyclic compounds of the formula wherein R1, R2, R3, U, V, W, X, Y, Z and n are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16 or 17,...
|
JP4613366B2 |
The present invention relates to new compounds represented by Formula I: wherein M represents a macrolide subunit of the substructure II: L represents the chain of the substructure III: -X 1 -(CH 2 ) m -Q...
|
JP2010275388A |
To provide a photobase generator achieving both of improvement in photosensitive performance by shifting an absorption wavelength for light to a longer wavelength and improvement in heat-resistant stability, to provide a photosensitive r...
|
JP4595417B2 |
|
JP4571639B2 |
The invention relates to malonamide derivatives of formula wherein each of the variables are as defined herein and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures ther...
|
JP2010532658A |
An in vitro method of screening for candidate compounds for the preventive or curative treatment of acne entails determination of the ability of a compound to inhibit the expression or the activity of TACE, and also to the administration...
|
JP2010229153A |
To provide compounds blocking activity of γ-secretase able to be used for treating Alzheimer's disease.Malonamide derivatives expressed by formula (I) [in formula (I), R1 represents a group expressed by formula (a)], pharmaceutically su...
|
JP2010209032A |
To provide a new compound changing an angle of rotation by exposure to light. The optically active compound is represented by general formula (1) (wherein X1-4are each-NH2or the like; a and b are each an integer of 1-6; and R1and R2are e...
|
JP4538112B2 |
A process for the production of polyisocyanates having at least 30 mol% iminooxadiazindione group content comprises use of a quat. ammonium and/or phosphonium fluoride catalyst with a solvating agent. A process for the production of poly...
|
JP4523593B2 |
The invention relates to N-sulfonyl-α-amino-acetic acid derivatives of the general formula (I): including the optical isomers thereof and mixtures of such isomers, wherein Ar1 and Ar2 independently of each other stand for an optionally ...
|
JP4519217B2 |
A process for the production of polyisocyanates having at least 30 mol% iminooxadiazindione group content comprises use of a quat. ammonium and/or phosphonium fluoride catalyst with a solvating agent. A process for the production of poly...
|
JP2010520915A |
The present invention relates to a compound of Formula (I), its geometrical isomers, in an optically active form as enantiomers, diastereomers, as well as in the form of racemate, as well as pharmaceutically acceptable salts thereof, whe...
|